Results 11 to 20 of about 3,179,450 (287)

Circulating Tumor DNA

The Journal of Molecular Diagnostics, 2023
For patients with BRAF wild-type stage III and IV melanoma, there is an urgent clinical need to identify prognostic biomarkers and biomarkers predictive of treatment response.
Lauren G. Aoude, Pearson, John, Smithers, B Mark, Patel, Kalpana, Kalpana Patel, Andrew P. Barbour, Sandra Brosda, Scott Wood, Jessica Ng, Brosda, Sandra, B. Mark Smithers, Lambros T. Koufariotis, Lonie, James M, Koufariotis, Lambros T, Vanessa F. Bonazzi, Aoude, Lauren G, Waddell, Nicola, James M. Lonie, Nicola Waddell, Barbour, Andrew P, Belle, Clemence J, Clemence J. Belle, John V. Pearson, Ng, Jessica, Bonazzi, Vanessa F, Atkinson, Victoria, Wood, Scott, Victoria Atkinson   +27 more
core   +2 more sources

Circulating Tumor DNA in Pediatric Cancer

Frontiers in Molecular Biosciences, 2022
The measurement of circulating tumor DNA (ctDNA) has gained increasing prominence as a minimally invasive tool for the detection of cancer-specific markers in plasma.
Louise Doculara, Louise Doculara, Louise Doculara, Toby N. Trahair, Toby N. Trahair, Toby N. Trahair, Narges Bayat, Narges Bayat, Narges Bayat, Richard B. Lock, Richard B. Lock, Richard B. Lock   +11 more
doaj   +4 more sources

Supplementary Figure from Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma

, 2021
Supplementary Figure from Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell ...
John N. Waldron (15032258), Daniel D. De Carvalho (15032261), Sareh Keshavarzi (5143991), Ilan Weinreb (5166416), Lillian L. Siu (14851075), Wei Xu (28953), Yangqiao Zheng (15032249), David P. Goldstein (9316874), Zhen Zhao (159931), Michael M. Hoffman (12856916), Justin M. Burgener (11502472), Jinfeng Zou (201031), Fei-Fei Liu (9030140), Geoffrey Liu (9416973), Anna Spreafico (4823517), John R. de Almeida (3805210), Shu Yi Shen (15032252), Scott V. Bratman (14936316), Shao Hui Huang (15032255)   +18 more
core   +10 more sources

Fragment Length of Circulating Tumor DNA.

PLoS Genetics, 2016
Malignant tumors shed DNA into the circulation. The transient half-life of circulating tumor DNA (ctDNA) may afford the opportunity to diagnose, monitor recurrence, and evaluate response to therapy solely through a non-invasive blood draw.
Hunter R Underhill, Jacob O Kitzman, Sabine Hellwig, Noah C Welker, Riza Daza, Daniel N Baker, Keith M Gligorich, Robert C Rostomily, Mary P Bronner, Jay Shendure   +9 more
doaj   +3 more sources

Cell-free circulating tumor DNA in cancer [PDF]

Chinese Journal of Cancer, 2016
Cancer is a common cause of death worldwide. Despite significant advances in cancer treatments, the morbidity and mortality are still enormous. Tumor heterogeneity, especially intratumoral heterogeneity, is a significant reason underlying difficulties in
Zhen Qin, Vladimir A. Ljubimov, Cuiqi Zhou, Yunguang Tong, Jimin Liang   +4 more
doaj   +5 more sources

Analytical evaluation of circulating tumor DNA sequencing assays

Scientific Reports
In China, circulating tumor DNA analysis is widely used and numerous assays are available. Systematic evaluation to help users make informed selections is needed.
Wenjin Li, Xiayu Huang, Rajesh Patel, Erica Schleifman, Shijing Fu, David S. Shames, Jingyu Zhang   +6 more
doaj   +2 more sources

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA [PDF]

Molecular Cancer, 2019
Hepatocellular carcinoma (HCC) is one of the most common cancers and a leading cause of death worldwide. Due to latent liver disease, late diagnosis, and nonresponse to systemic treatments, surgical resection and/or biopsy specimens are still generally ...
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu   +3 more
doaj   +3 more sources

Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA

Tumor Biology, 2018
Biomarkers are the key to personalized treatment in patients with breast cancer. While tissue biomarkers are most useful in determining prognosis and upfront predicting response to therapy, circulating protein biomarkers such as CA 15-3 and ...
Michael J Duffy, Enda W McDermott, John Crown   +2 more
doaj   +2 more sources

Clinical Application of Circulating Tumor DNA Analysis [PDF]

, 2022
Liquid biopsy using circulating tumor DNA helps overcome the limitations of conventional tissue testing. Non-invasive molecular profiling using circulating tumor DNA is increasingly being used to diagnose cancer, stratify risk, and select targeted ...
이승태, 원동주, 신새암
core   +1 more source

The role of circulating tumor DNA in ovarian cancer. [PDF]

Discov Oncol
Ovarian cancer is the deadliest of all gynecological diseases because its diagnosis and treatment still pose many problems. Surgical excision, hormone therapy, radiation, chemotherapy, or targeted therapy for eradicating the main tumor and halting the spread of metastases are among the treatment options available to individuals with ovarian cancer ...
Abulajiang Y, Ming W, Wu Y.
europepmc   +3 more sources